News Conference News ACC 2018 Wearable Cardioverter-Defibrillator Fails to Meet Primary Endpoint in First Randomized Trial Todd Neale March 10, 2018
News Conference News ACC 2018 Googling of Cardiac Symptoms Tracks With Hospital Admissions for Coronary Disease Yael L. Maxwell March 09, 2018
News Conference News ACC 2018 Inflammatory Bowel Disease May Up the Risk of MI, Especially in Young People L.A. McKeown March 09, 2018
News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018
News Conference News ACC 2018 Big Swings in Daily Temperatures Linked to Spikes in MI Rates L.A. McKeown March 02, 2018
News Conference News ACC 2018 Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis Michael O'Riordan March 01, 2018
News Conference News ACC 2018 Preeclampsia During Pregnancy Linked With CV Consequences Many Years Later Caitlin E. Cox February 28, 2018
News Conference News ACC 2017 Simplified MRI Imaging Tests May Help ID Kids at High CV Risk During Sports Michael O'Riordan March 24, 2017
News Conference News ACC 2017 Many Patients Prescribed PCSK9 Inhibitors Never End Up Getting Them Yael L. Maxwell March 23, 2017
News Conference News ACC 2017 High-Dose Atorvastatin Does Not Impact Cognition, but Small Changes Observed on Brain MRI Michael O'Riordan March 21, 2017
Presentation ACC 2017 EINSTEIN CHOICE: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism Presenter: Jeff Weitz March 20, 2017
News Conference News ACC 2017 Going to Low LDL Levels With Evolocumab Does Not Affect Memory, Brain Function: EBBINGHAUS Michael O'Riordan March 19, 2017
News Conference News ACC 2017 Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery Michael O'Riordan March 19, 2017
News Conference News ACC 2017 CARAT: Novel HDL Mimetic Fails to Show Benefit in Coronary Atherosclerosis After ACS Yael L. Maxwell March 18, 2017
News Conference News ACC 2017 Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE L.A. McKeown March 18, 2017
News Conference News ACC 2017 Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe Todd Neale March 18, 2017
News Conference News ACC 2017 ORION-1: Novel LDL-Lowering Treatment Could Reduce Costs, Increase Adherence Over PCSK9s Yael L. Maxwell March 17, 2017
News Conference News ACC 2017 People Living in Amazon Rainforest Provide Clues to Coronary Protection L.A. McKeown March 17, 2017
News Conference News ACC 2017 SPIRE 1 and 2: Support for PCSK9 Inhibition but Not Bococizumab Yael L. Maxwell March 17, 2017